Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H de Verneuil

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
La Nouvelle Presse Medicale|November 28, 1981
[Familial and sporadic porphyria cutanea symptomatica (author's transl)]H de Verneuil, Y Nordmann
Nucleic Acids Research|August 11, 1990
The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the proteinH de Verneuil, D Metzger
Human Genetics|October 31, 1978
Familial and sporadic porphyria cutanea: two different diseasesH de Verneuil, G Aitken, Y Nordmann
Biochimica Et Biophysica Acta|January 11, 1980
Some kinetic properties of human red cell uroporphyrinogen decarboxylaseH de Verneuil, B Grandchamp, Y Nordmann
The Biochemical Journal|July 15, 1983
Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyriaH De Verneuil, S Sassa, A Kappas
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells]H de Verneuil, F Moreau-Gaudry, C Ged
Human Genetics|January 1, 1981
The inherited enzymatic defect in porphyria variegataJ C Deybach, H de Verneuil, Y Nordmann
The Journal of Biological Chemistry|August 15, 1985
Accumulation of porphobilinogen deaminase, uroporphyrinogen decarboxylase, and alpha- and beta-globin mRNAs during differentiation of mouse erythroleukemic cells. Effects of succinylacetoneB Grandchamp, C Beaumont, H de Verneuil, et al.
Journal of Bioenergetics and Biomembranes|April 1, 1995
Porphyrias: animal models and prospects for cellular and gene therapyH de Verneuil, C Ged, S Boulechfar, et al.
Transactions of the Association of American Physicians|January 1, 1983
Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tardaS Sassa, H de Verneuil, K E Anderson, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
La Nouvelle Presse Medicale|November 28, 1981
[Familial and sporadic porphyria cutanea symptomatica (author's transl)]H de Verneuil, Y Nordmann
Nucleic Acids Research|August 11, 1990
The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the proteinH de Verneuil, D Metzger
Human Genetics|October 31, 1978
Familial and sporadic porphyria cutanea: two different diseasesH de Verneuil, G Aitken, Y Nordmann
Biochimica Et Biophysica Acta|January 11, 1980
Some kinetic properties of human red cell uroporphyrinogen decarboxylaseH de Verneuil, B Grandchamp, Y Nordmann
The Biochemical Journal|July 15, 1983
Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyriaH De Verneuil, S Sassa, A Kappas
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells]H de Verneuil, F Moreau-Gaudry, C Ged
Human Genetics|January 1, 1981
The inherited enzymatic defect in porphyria variegataJ C Deybach, H de Verneuil, Y Nordmann
The Journal of Biological Chemistry|August 15, 1985
Accumulation of porphobilinogen deaminase, uroporphyrinogen decarboxylase, and alpha- and beta-globin mRNAs during differentiation of mouse erythroleukemic cells. Effects of succinylacetoneB Grandchamp, C Beaumont, H de Verneuil, et al.
Journal of Bioenergetics and Biomembranes|April 1, 1995
Porphyrias: animal models and prospects for cellular and gene therapyH de Verneuil, C Ged, S Boulechfar, et al.
Transactions of the Association of American Physicians|January 1, 1983
Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tardaS Sassa, H de Verneuil, K E Anderson, et al.
Pageof 9